A share price of Catheter Precision Inc [VTAK] is currently trading at $0.37, down -15.12%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VTAK shares have gain 72.41% over the last week, with a monthly amount glided 22.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Catheter Precision Inc [AMEX: VTAK] stock has seen the most recent analyst activity on August 13, 2019, when Piper Jaffray downgraded its rating to a Neutral and also revised its price target to $1.50 from $9. Previously, Maxim Group started tracking the stock with Buy rating on November 02, 2018, and set its price target to $23.
Catheter Precision Inc experienced fluctuations in its stock price throughout the past year between $0.16 and $8.40. Catheter Precision Inc [AMEX: VTAK] shares were valued at $0.37 at the most recent close of the market.
Analyzing the VTAK fundamentals
Trailing Twelve Months sales for Catheter Precision Inc [AMEX:VTAK] were 0.48M which represents 74.39% growth. Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -25.35%, Pretax Profit Margin comes in at -32.42%, and Net Profit Margin reading is -37.45%. To continue investigating profitability, this company’s Return on Assets is posted at -0.73, Equity is -1.54 and Total Capital is -0.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3208 points at the first support level, and at 0.2766 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4284, and for the 2nd resistance point, it is at 0.4918.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Catheter Precision Inc [AMEX:VTAK] is 0.21. In addition, the Quick Ratio stands at 0.19 and the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 9.58, the price to book ratio is 0.43.
Transactions by insiders
Recent insider trading involved COLOMBATTO MARTIN J, Director, that happened on Jan 29 ’25 when 3.0 shares were sold.
